James Sherblom

Insider Reports History

Location
Woburn, MA
Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Sherblom:

Company Role Class Num Shares Value Price $ Report Date Ownership
Comera Life Sciences Holdings, Inc. Director Stock Option (Right to Purchase) 103,643 09 Nov 2023 Direct

Insider Reports Filed by James Sherblom

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000106299323020807-sherblom-james-2023-11-09 Comera Life Sciences Holdings, Inc. 09 Nov 2023 1 $0 4 Director 14 Nov 2023, 16:31
/report/000106299323017441-sherblom-james-2023-08-31 Comera Life Sciences Holdings, Inc. 31 Aug 2023 1 $0 4 Director 01 Sep 2023, 16:45
/report/000106299323011247-sherblom-james-2023-05-12 Comera Life Sciences Holdings, Inc. 12 May 2023 1 $0 4 Director 16 May 2023, 17:46
/report/000106299323003849-sherblom-james-2023-02-14 Comera Life Sciences Holdings, Inc. 14 Feb 2023 1 $0 4 Director 16 Feb 2023, 17:33
/report/000106299323003511-sherblom-james-2023-01-04-restatement Comera Life Sciences Holdings, Inc. 04 Jan 2023 2 +$120,000 4/A Director 14 Feb 2023, 16:47
/report/000106299323003521-sherblom-james-2022-12-31 Comera Life Sciences Holdings, Inc. 31 Dec 2022 1 $0 5 Director 14 Feb 2023, 16:58
/report/000106299322019486-sherblom-james-2022-09-12 Comera Life Sciences Holdings, Inc. 12 Sep 2022 1 +$101,500 4 Director 12 Sep 2022, 17:25
/report/000089924322019138-sherblom-james-2022-05-19 Comera Life Sciences Holdings, Inc. 19 May 2022 0 $0 3 Director 20 May 2022, 19:38